Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
{{output}}
This study investigated preventative and therapeutic agents against human T cell lymphotropic virus type-1 subtype-C (HTLV-1c) infection. We established and characterized a humanized mouse model of HTLV-1c infection and identified that HTLV-1c disease appears ... ...
